The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of LTHM, HRTX and TUSK
Monday, July 15, 2019 8:30 PM
NEW YORK, NY / ACCESSWIRE / July 15, 2019 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Livent Corporation (NYSE: LTHM)
Class Period: on behalf of persons and entities that purchased or otherwise acquired Livent securities pursuant and/or traceable to initial public offering on or around October 11, 2018.
Lead Plaintiff Deadline: July 22, 2019
Livent Corporation allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) a supply contract with Nemaska Lithium Inc. had been terminated; (2) as a result, the Company would be forced to fulfill its customer contracts using alternative vendors at reduced revenues and lower margins; (3) the Company had a long-standing contract to supply lithium hydroxide to a customer at a much lower price than any of the Company's existing contracts; (4) the Company's margins were squeezed due to the customer's increased orders; and (5) as a result of the foregoing, Defendants positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.
Get additional information about the LTHM lawsuit: http://www.kleinstocklaw.com/pslra-1/livent-corporation-loss-submission-form?id=2422&from=1
Heron Therapeutics, Inc. (NASDAQ: HRTX)
Class Period: October 31, 2018 to April 30, 2019
Lead Plaintiff Deadline: August 5, 2019
During the class period, Heron Therapeutics, Inc. allegedly made materially false and/or misleading statements and/or failed to disclose that: (i) Heron had failed to include adequate Chemistry, Manufacturing, and Controls (“CMC”) and non-clinical information in its NDA for HTX-011; (ii) the foregoing increased the likelihood that the FDA would not approve Heron’s NDA for HTX-011; and (iii) as a result, Heron’s public statements were materially false and misleading at all relevant times.
Get additional information about the HRTX lawsuit: http://www.kleinstocklaw.com/pslra-1/heron-therapeutics-inc-loss-submission-form?id=2422&from=1
Mammoth Energy Services, Inc. (NASDAQ: TUSK)
Class Period: October 19, 2017 to June 5, 2019
Lead Plaintiff Deadline: August 9, 2019
The lawsuit alleges Mammoth Energy Services, Inc. made materially false and/or misleading statements and/or failed to disclose during the class period that: (1) Mammoth’s subsidiary, Cobra, improperly obtained two infrastructure contracts with PREPA that totaled over $1.8 billion; (2) specifically, the contracts were awarded as the result of improper steering and not a competitive RFP process; and (3) as a result, Defendants’ statements about Mammoth’s business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Get additional information about the TUSK lawsuit: http://www.kleinstocklaw.com/pslra-1/mammoth-energy-services-inc-loss-submission-form?id=2422&from=1
Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff. There is no cost or obligation to you. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
New York, NY 10118
Telephone: (212) 616-4899
Fax: (347) 558-9665
SOURCE: The Klein Law Firm